Sam Altman-Backed Retro Biosciences Raises $1B to Extend Human Lifespan

OpenAI’s Sam Altman is backing Retro Biosciences’ ambitious $1B fundraising round to develop longevity drugs targeting diseases like Alzheimer’s. The Billion-Dollar Bet on Longevity: Sam Altman’s Vision for Extending Life … Read More

China’s AI Surge: How Beijing is Reshaping the Global Tech Landscape

China’s AI and semiconductor industries are rapidly advancing despite Western restrictions. Can Beijing challenge the U.S. in the race for artificial intelligence dominance? China’s AI Renaissance: Defying the Odds Amid … Read More

Global Stocks Slip Amid AI Investment Buzz and Tariff Worries

Global markets waver as AI infrastructure investments fuel rallies, while U.S. tariff threats create economic uncertainty. AI Investment Hype Fades as Global Stocks Stumble Global stock markets pulled back on … Read More

OpenAI to Reportedly Launch AI Super-Agents with PhD-Level Intelligence

Summary: OpenAI is reportedly set to launch AI super-agents with PhD-level intelligence as early as January 30. These advanced AI systems, capable of performing complex tasks independently, may revolutionize productivity … Read More

Taiwan’s Exemption from U.S. AI Export Curbs: Key Insights

Taiwan secures “tier one” status under U.S. AI export rules, highlighting its robust controls and commitment to legal compliance. Taiwan’s Exemption from U.S. AI Export Curbs Signals Trust in Regulatory … Read More

Microsoft Forms New AI-Centric Development Division to Lead Innovation

Microsoft launches CoreAI, a new engineering division focused on advancing AI infrastructure and model-forward applications. Led by Jay Parikh, CoreAI aims to revolutionize software development. Microsoft has launched a groundbreaking … Read More